Please login to the form below

Not currently logged in
Email:
Password:

Spirogen

This page shows the latest Spirogen news and features for those working in and with pharma, biotech and healthcare.

MedImmune partners with US National Cancer Institute

MedImmune partners with US National Cancer Institute

AZ boosted its pipeline in thsi area with the $440m acquisition of Spirogen.

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Pharma deals during October 2013 Pharma deals during October 2013

    Auven's portfolio of companies includes Resolvyx, Kiacta, Kolitan and Sprout Pharmaceuticals, as well as Spirogen and ADC Therapeutics. ... The Spirogen/Auven Therapeutics deal with MedImmune discussed above re-confirms that ADC technology is certainly

  • Deal Watch table for October 2013 Deal Watch table for October 2013

    730. Spirogen / MedImmune. Acquisition. ADC technology - oncology (lead asset in phase II).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics